October 25, 2019
Neopharma, Elevar Therapeutics form JV to sell anticancer drug Rivoceranib
Abu Dhabi-based pharmaceutical manufacturer Neopharma and US-based Elevar Therapeutics formed a 50-50 joint venture in UAE, to organize selling Rivoceranib, a targeted anticancer drug and conduct clinical trials for other pipeline candidates.